Immunologic Responses to a Live Attenuated Oral Cholera Vaccine
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Nov 2017
At a glance
- Drugs PXVX 0200 (Primary)
- Indications Cholera
- Focus Pharmacodynamics
- 30 Oct 2017 Planned End Date changed from 31 Dec 2018 to 30 Nov 2018.
- 30 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 18 Aug 2017 New trial record